Article examines the persistent underreporting of Adverse Drug Reactions (ADRs) in India despite advancements in pharmacovigilance. It highlights key barriers such as lack of awareness, inadequate training, workload pressures, and poor infrastructure. Moreover, it emphasizes education, digital reporting tools, and supportive reporting cultures to strengthen medicine safety.
Underreporting of Adverse Drug Reactionsin India: Challenges and Solutions
